Viking Therapeutics
VKTX
VKTX
134 hedge funds and large institutions have $238M invested in Viking Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 47
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
Holders
134
Holding in Top 10
–
Calls
$8.98M
Puts
$1.56M
Top Buyers
| 1 | +$5.55M | |
| 2 | +$2.71M | |
| 3 | +$2.03M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$646K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$621K |
Top Sellers
| 1 | -$5.93M | |
| 2 | -$1.23M | |
| 3 | -$1.2M | |
| 4 |
Goldman Sachs
New York
|
-$951K |
| 5 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$770K |